Guaifenesin Tablet, Extended Release
Product Images NDC 58602-853

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Guaifenesin (NDC 58602-853). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aurohealth Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Package Label-principal Display Panel (600 mg (20 Tablet Label))

Package Label-principal Display Panel (600 mg (20 Tablet Label))
FDA Label Image

Package Label-principal Display Panel (600 mg (20 Tablet Carton Label))

Package Label-principal Display Panel (600 mg (20 Tablet Carton Label))
FDA Label Image

Package Label-principal Display Panel (600 mg Blister Carton (20 (1 x 20) Tablets))

Package Label-principal Display Panel (600 mg Blister Carton (20 (1 x 20) Tablets))
This is a medication called "Expectorant" sold in a package of 20 extended-release tablets. It claims to relieve chest congestion and thin and loosen mucus. The active ingredient in each tablet is Guath USP 600 g. It is in comparison with Mucinex® and the product was not manufactured or distributed by its distributor. It provides customer service information for more details.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.